RxDoctor Payments Data

Steven Wagner, MD

Vascular & Interventional Radiology · Doylestown, PANPI 1659366896

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $29,631 of the $37,457 with a category attached, or 79.1%. Genentech, Inc. accounts for 68.8% of it on its own, with 28 other manufacturers making up the rest. Reporting peaked in 2019 at $15,951 and has fallen 88.9% since, to $1,769 in 2025. Among vascular & interventional radiology clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$37,457in general payments, 2019–2025

Across 126 payments — averaging $297.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Genentech, Inc.$26K
  • Siemens Medical Solutions USA, Inc.$4K
  • Canon Medical Systems USA, Inc.$1K
  • Inari Medical, Inc.$1K
  • Sirtex Medical Inc$975
  • Penumbra, Inc.$839
  • plus $3K from 23 others
$400,331in research payments, 2019–2025

Across 157 payments — averaging $2549.88 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Regeneron$348K
  • Amgen$24K
  • Genentech, Inc.$19K
  • Bristol Myers Squibb$7K
  • Hexal AG$2K

What the payments were for

  • Consulting fees$29,63179%
  • Travel & lodging$1,0313%
  • Food & beverage$6,66918%
  • Entertainment$1250%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$37,457 in reported general payments places this provider in the 90th percentile of 223 vascular & interventional radiology providers in Pennsylvania.

See all vascular & interventional radiology providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$106,883
Medicare patients
1,760
Services billed
2,424

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other vascular & interventional radiology in Doylestown

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →